Hepatic regeneration pathways

Hepatic regeneration pathways encompass the coordinated molecular events that allow the liver to recover its mass and function following surgical resection or chemical injury (Michalopoulos, 2017). This process is primarily driven by the compensatory hyperplasia of mature hepatocytes, which exit their quiescent G0 state to enter the cell cycle (Fausto et al., 2006). Key signaling cascades involved include the HGF/MET and EGF/EGFR pathways, which act as primary mitogens, and the IL-6/STAT3 and TNF-alpha/NF-kappaB pathways, which prime hepatocytes for replication (Taub, 2004). Developmental pathways such as Wnt/beta-catenin and Notch also play critical roles in spatial organization and cell fate during the regenerative process (Forbes & Newsome, 2016). In clinical settings, these pathways are therapeutic targets for treating acute liver failure and promoting recovery after transplantation. Conversely, chronic over-activation of these same pathways is frequently observed in hepatocellular carcinoma, where they drive malignant cell proliferation. Pharmacological intervention involves using growth factor mimetics to stimulate repair or kinase inhibitors to block aberrant signaling in cancer. Understanding the balance between pro-regenerative and termination signals, such as TGF-beta, is vital for developing safe and effective liver-directed therapies.

Other names

Liver regenerationHepatocyte proliferation pathwaysCompensatory hyperplasia of the liver

Activation of mitogenic growth factor receptors (e.g., MET), cytokine-mediated priming of hepatocytes (e.g., STAT3), and modulation of developmental signaling pathways (e.g., Wnt/beta-catenin) to stimulate cell cycle entry and tissue mass restoration.